APA (7th ed.) Citation

W, X., D, Z., Y, M., RC, G., M, K., A, N., . . . GI, S. (2024). Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway. Cell reports, 43(10), 114746. https://doi.org/10.1016/j.celrep.2024.114746

Chicago Style (17th ed.) Citation

W, Xu, Zhang D, Ma Y, Gaspar RC, Kahn M, Nasiri A, Murray S, Samuel VT, and Shulman GI. "Ceramide Synthesis Inhibitors Prevent Lipid-induced Insulin Resistance Through the DAG-PKCε-insulin ReceptorT1150 Phosphorylation Pathway." Cell Reports 43, no. 10 (2024): 114746. https://doi.org/10.1016/j.celrep.2024.114746.

MLA (9th ed.) Citation

W, Xu, et al. "Ceramide Synthesis Inhibitors Prevent Lipid-induced Insulin Resistance Through the DAG-PKCε-insulin ReceptorT1150 Phosphorylation Pathway." Cell Reports, vol. 43, no. 10, 2024, p. 114746, https://doi.org/10.1016/j.celrep.2024.114746.